Founded in 2016 by Wang Xingxing — who built his first quadruped as a graduate student — Unitree has become the most prolific humanoid maker on earth by volume, and the one that broke the price floor. While Western rivals quote six figures or "contact sales," Unitree ships a walking humanoid, the G1 (127 cm, 47 kg), from around $16,000 — the price of a modest car, not a house.
The bet: win on price and volume
Its strategy is ruthlessly vertical: it designs and builds its own actuators, motors, harmonic drives and LiDAR, sells into a deep research-and-developer ecosystem, and iterates in public with viral demos — sixteen of its H1 robots dancing on China's 2025 Spring Festival Gala, a humanoid kickboxing tournament, gold medals at the 2025 World Humanoid Robot Games. The trade-off is honesty about purpose: these are research and embodied-AI platforms, not companions. There's no synthetic face, no warmth, no pretense of a relationship — and the demos lean on teleoperation and choreography rather more than the clips let on.
Where it stands
Unitree is the rare humanoid maker that actually makes money. Its IPO prospectus reported 2025 revenue around $257M — up more than 300% year on year — and a real profit, making it, by its own account, the only profitable humanoid company in the world, having shipped roughly 5,500 humanoids that year. In June 2026 it cleared the listing committee for a Shanghai STAR Market IPO at a target valuation near $6.2 billion, putting it on course to be China's first publicly traded humanoid maker. Its 2026 shipment target of 20,000 units and its self-declared global volume lead are company claims; the audited financials underneath are not.
Unitree matters to this site as the cost-curve setter. When the cheapest credible humanoid body comes from Hangzhou at a five-figure price — built on actuators a companion maker would otherwise have to buy or invent — every rival's bill of materials is measured against it. The face and the warmth are someone else's problem to add; Unitree's job is to make the body cheap, and at that it is winning.